Thanks NI, several items that disserve repeating :
Post# of 8376
(Total Views: 409)
Posted On: 11/25/2020 3:16:03 PM
Re: normal_investor #2821
Thanks NI, several items that disserve repeating :
* Early December Device delivery to complete initial Scott order for DonJoy EME Products, Q4 Revenue, 2nd Device Order due early 2021
* The two other US OEM Partners will receive their Device Orders in December also, Q4 Revenue, Retail Sales start Q1 2021, Start of Retail Sales identifies Partners
* Adcock Ingram is a major African Medical Product Distributor/Mfg., 120 year old company, $481 million Sales in last year, 2600 Employees, , Part of the Bidvest Group with 132,000 Employees, Orders begin shipping early 2021
* CE Mark generating orders in EU, shipping Q4 2020 & Q1 2021, Q4 Revenue and Q1 2021 Revenue
* RecoveryRx US Marketing has resulted in 1,500 samples distributed to Medical Professionals via 275 Sales Reps
* R&D, Neck Study that shows good efficacy and central sensitization mechanism of action has been accepted for publication, Research started into how Device affects Brain Waves, possible new applications.
* Early December Device delivery to complete initial Scott order for DonJoy EME Products, Q4 Revenue, 2nd Device Order due early 2021
* The two other US OEM Partners will receive their Device Orders in December also, Q4 Revenue, Retail Sales start Q1 2021, Start of Retail Sales identifies Partners
* Adcock Ingram is a major African Medical Product Distributor/Mfg., 120 year old company, $481 million Sales in last year, 2600 Employees, , Part of the Bidvest Group with 132,000 Employees, Orders begin shipping early 2021
* CE Mark generating orders in EU, shipping Q4 2020 & Q1 2021, Q4 Revenue and Q1 2021 Revenue
* RecoveryRx US Marketing has resulted in 1,500 samples distributed to Medical Professionals via 275 Sales Reps
* R&D, Neck Study that shows good efficacy and central sensitization mechanism of action has been accepted for publication, Research started into how Device affects Brain Waves, possible new applications.
(2)
(0)